Compare BLTE & ERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BLTE | ERO |
|---|---|---|
| Founded | 2018 | 2016 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 1.5B |
| IPO Year | 2022 | N/A |
| Metric | BLTE | ERO |
|---|---|---|
| Price | $154.30 | $25.04 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | ★ $149.00 | $25.00 |
| AVG Volume (30 Days) | 298.6K | ★ 1.0M |
| Earning Date | 11-10-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 696.31 |
| EPS | N/A | ★ 1.33 |
| Revenue | N/A | ★ $588,229,000.00 |
| Revenue This Year | N/A | $68.14 |
| Revenue Next Year | N/A | $46.45 |
| P/E Ratio | ★ N/A | $18.81 |
| Revenue Growth | N/A | ★ 26.74 |
| 52 Week Low | $49.00 | $9.30 |
| 52 Week High | $161.32 | $26.77 |
| Indicator | BLTE | ERO |
|---|---|---|
| Relative Strength Index (RSI) | 66.31 | 58.87 |
| Support Level | $141.00 | $24.80 |
| Resistance Level | $161.32 | $26.65 |
| Average True Range (ATR) | 9.85 | 1.14 |
| MACD | -1.19 | -0.07 |
| Stochastic Oscillator | 76.02 | 43.22 |
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.
Ero Copper Corp is a base metals mining company. It is predominantly focused on the production and sale of copper with gold and silver produced and sold as by-products. Ero's operations are segmented between its mines in Brazil, the Caraiba Operations and the Xavantina Operations, its development project, the Tucuma Project in Brazil and corporate. Majority of its revenue is generated from its Caraiba Operations segment which consists of mining operations and processing facilities including the Pilar and Vermelhos underground mines and the Surubim open pit mine.